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LETTERS TO THE EDITOR
Regarding: “Initial experience with eversion carotid
endarterectomy: Absence of a learning curve for the
first 100 patients”
We read with interest Dr Brothers’ article on his initial experience
with eversion carotid endarterectomy (eCEA).1 Comparing his first
100 patients who underwent eCEA with 100 cases of traditional CEA
and patching (tCEA), he found a significantly higher rate of resteno-
ses 50% in the former (38% vs 6%) and no evidence of a learning
curve. Shunting was also needed more often during eCEA (87% vs
59%), and four carotid occlusions occurred 36 months of eCEA
compared with only one occlusion after tCEA. Hence, the author’s
concern about eCEA, and he urges surgeons undertaking eCEA to
monitor their initial results carefully.
In a recently published study on 1150 CEAs performed in
1000 patients, we compared the outcome of 848 eCEAs with 302
tCEAs.2 Unlike Dr Brothers, we found that eCEA reduced peri-
operative (30-day) mortality (0% vs 1.2%) and stroke risk rates
(0.3% vs 0.6%). In6 years of follow-up, only two restenoses (one
50% and 1 70%) and 1 occlusion occurred in the eversion
group.
Because group comparability in terms of external and intrinsic
vascular risk factors is always crucial, a few years ago we conducted
a prospective randomized study comparing clinical outcome and
incidence of restenosis in 86 patients who had tCEA on one side
and eCEA on the other.3 Selective shunting was statistically higher
in the tCEA group (39.5% vs 1.2%), and patched patients had a
slightly higher rate of combined transient ischemic attacks and
strokes (7% vs 1.2%). Most importantly, patched patients had a
significantly higher incidence of restenosis50% (4.7% vs 0%) and
combined occlusions and restenoses (13% vs 1.2%), with a signifi-
cantly worse cumulative patency rate and freedom from restenoses
at 2 and 3 years (P  .001).
Several statistically and clinically significant findings relate to
the better early results with eCEA.3 First, the higher incidence of
residual angulations after patching, compared with the lack of
residual distal elongation with eversion (10.5% vs 0%), indicates
that this defect may be a major determinant of perioperative stroke
secondary to primary thrombosis and a predictor for late occlu-
sions. Second, eCEA takes less time than tCEA (mean carotid
cross-clamping time of 9 minutes vs 21 minutes), significantly
reducing the need for shunting (1.2 % vs 39.5%). Finally, eCEA
preserves the original carotid configuration, offering theoretical
hemodynamic advantages in terms of minimizing turbulence and
the potential for restenosis.3,4 So, in our hands eCEA is a safe,
effective, and durable procedure.
Dr Brothers’ results are plausible, but his study has several
weaknesses: (1) being retrospective, the analysis can have no sig-
nificant clinical implications; (2) the timing of enrollment differs
between the groups, (3) the incidence of important risk factors
such as diabetes and hypertension in each group and (4) the drop
out rate are not known; (5) carotid plaque morphology (low vs
high embolic risk) is never mentioned, and (6) no carotid imaging
was performed on the restenoses.
We agree with Dr Brothers that it is always wise to carefully
monitor initial results after adopting a new technique, bearing in
mind the experience of other colleagues.
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Reply
Dr Baracchini and his colleagues are to be congratulated for
their excellent results with eversion carotid endarterectomy. While
laudable, their findings of reduced perioperative 30-day mortality
and stroke with the eversion technique do not appear to be
statistically significantly lower than their outstanding results with
traditional endarterectomy and patching (my calculation using
Fisher’s exact test). Certainly, their extremely low rate of restenosis
of1% in their retrospective study appears to be far superior of that
of 3.6% documented for eversion endarterectomy in the much
larger prospective, randomized Eversion Endarterectomy versus
Standard Trial (EVEREST) trial.1 Clearly, few vascular surgeons
have been able to achieve the surgical precision of Dr Baracchini
with this technique, and I welcome his comments.
I readily acknowledge that my report suffers from all of the
inherent weakness of a retrospective study, as does his own 2004
study. Although not reported in my article, there were no differ-
ences in the prevalence of diabetes and hypertension between the
groups. The dropout rate is included with the life-table analysis.
Finally, although I do share his intellectual curiosity regarding
the angiographic appearance of the carotids detected to have
50% stenosis by duplex, ethically, I did not feel that I could study
these patients angiographically unless their degree of stenosis was
80%. I am glad that we agree that all surgeons must carefully
monitor their own results.
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